AMPLITUDE Clinical Research Study – Investigating APOL1-Mediated Kidney Disease Treatment - Vertex Pharmaceuticals - Cough Health

The AMPLITUDE study is a Phase I clinical trial investigating a potential treatment for APOL1-mediated kidney disease, a form of chronic kidney disease affecting individuals of African ancestry. Led by VERTEX Pharmaceuticals in partnership with COUCH Health and 1nHealth, this study explores the safety and efficacy of an investigational drug previously tested in healthy volunteers and patients with similar conditions. As a Medical Contact Specialist and Patient Recruiter, responsibilities included ensuring compliance with GCP and EU clinical trial regulations, engaging diverse communities, and supporting ethical participant recruitment and communication strategies.

LANGUAGE SUPPORTED : SPANISH/ENGLISH